Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/29403
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | COURTWRIGHT, Andrew M. | - |
dc.contributor.author | BALDI, Bruno G. | - |
dc.contributor.author | KIDAMBI, Pranav | - |
dc.contributor.author | CUI, Ye | - |
dc.contributor.author | LAMATTINA, Anthony M. | - |
dc.contributor.author | VILLALBA, Julian A. | - |
dc.contributor.author | BAGWE, Shefali | - |
dc.contributor.author | GOLDBERG, Hilary J. | - |
dc.contributor.author | ROSAS, Ivan O. | - |
dc.contributor.author | HENSKE, Elizabeth Petri | - |
dc.contributor.author | CARVALHO, Carlos R. R. | - |
dc.contributor.author | EL-CHEMALY, Souheil | - |
dc.date.accessioned | 2018-11-21T17:00:34Z | - |
dc.date.available | 2018-11-21T17:00:34Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, v.35, n.3, p.206-212, 2018 | - |
dc.identifier.issn | 1124-0490 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/29403 | - |
dc.description.abstract | Background: A subset of lymphangioleiomyomatosis (LAM) patients present with normal FEV1 and FVC but with reduced DLCO. Patients with an isolated reduction in DLCO in other diseases appear to be at higher risk for pulmonary hypertension and worse survival but this has not been previously described in LAM patients. Objective: To characterize the prevalence and clinical progression of LAM patients who present with discordantly low DLCO. Methods: This was a retrospective cohort study of LAM patients in two centers in the United States and Brazil. Discordant DLCO was defined as FEV1 >80% predicted, FVC >80% predicted, and DLCO<80% predicted. We compared the rate of decline in pulmonary function, pulmonary artery to aorta (PA-A) ratio, and VEGF-D levels in patients with concordant and discordant DLCO. Results: The overall prevalence of discordant DLCO was 26.0%. Patients with discordant DLCO did not have a higher rate of yearly decline in FEV1 (-1.0 +/- 0.6 vs -1.0 +/- 0.6, p=0.50), FVC (-1.0 +/- 0.7 vs -0.3 +/- 0.8, p=0.54), or DLCO (-2.2 +/- 0.9 vs -1.6 +/- 0.6, p=0.79). They did not have higher rates of PA-A ratio>1 (23.3% vs 20.1%, p=1.00). Patients with discordant DLCO did not have higher levels of VEGF-D (1214 +/- 1256 pg/mL vs 1706 +/- 1214 pg/mL, p=0.07). Conclusions: LAM patients who present with a discordantly low DLCO do not appear to have different rates of decline in pulmonary function. Additional biological and radiographic markers are needed to more fully characterize this population. | - |
dc.description.sponsorship | National Institutes of Health [5T32HL007633-30] | - |
dc.description.sponsorship | Department of Defense [TS130031] | - |
dc.description.sponsorship | Anne Levine LAM research fund | - |
dc.description.sponsorship | Lucy J. Engles TSC/LAM Research Program | - |
dc.language.iso | eng | - |
dc.publisher | MATTIOLI 1885 | - |
dc.relation.ispartof | Sarcoidosis Vasculitis and Diffuse Lung Diseases | - |
dc.rights | restrictedAccess | - |
dc.subject | DLCO | - |
dc.subject | FEV1 | - |
dc.subject | lymphangioleiomyomatosis | - |
dc.subject | pulmonary artery to aorta ratio | - |
dc.subject | VEGF | - |
dc.subject.other | growth factor-d | - |
dc.subject.other | arterial enlargement | - |
dc.subject.other | nonsmoking patients | - |
dc.subject.other | reference values | - |
dc.subject.other | lung-function | - |
dc.subject.other | hypertension | - |
dc.subject.other | copd | - |
dc.subject.other | sirolimus | - |
dc.subject.other | diagnosis | - |
dc.subject.other | efficacy | - |
dc.title | CHARACTERIZATION OF LYMPHANGIOLEIOMYOMATOSIS PATIENTS WITH DISCORDANCE BETWEEN SPIROMETRIC AND DIFFUSION MEASUREMENTS OF PULMONARY FUNCTION | - |
dc.type | article | - |
dc.rights.holder | Copyright MATTIOLI 1885 | - |
dc.subject.wos | Respiratory System | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | COURTWRIGHT, Andrew M.:Hosp Univ Penn, Div Pulm & Crit Care Med, Philadelphia, PA USA; Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | KIDAMBI, Pranav:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | CUI, Ye:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | LAMATTINA, Anthony M.:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | VILLALBA, Julian A.:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | BAGWE, Shefali:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | GOLDBERG, Hilary J.:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | ROSAS, Ivan O.:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | HENSKE, Elizabeth Petri:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.author.external | EL-CHEMALY, Souheil:Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA | - |
hcfmusp.description.beginpage | 206 | - |
hcfmusp.description.endpage | 212 | - |
hcfmusp.description.issue | 3 | - |
hcfmusp.description.volume | 35 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000447628600004 | - |
hcfmusp.origem.id | 2-s2.0-85055249442 | - |
hcfmusp.publisher.city | FIDENZA | - |
hcfmusp.publisher.country | ITALY | - |
hcfmusp.relation.reference | ANDONOPOULOS AP, 1988, RESPIRATION, V53, P251 | - |
hcfmusp.relation.reference | ANDONOPOULOS AP, 1988, CHEST, V94, P312, DOI 10.1378/chest.94.2.312 | - |
hcfmusp.relation.reference | Bailey E, 2017, AM J PATHOL, V187, P25, DOI 10.1016/j.ajpath.2016.09.008 | - |
hcfmusp.relation.reference | Baldi BG, 2011, CLINICS, V66, P1301, DOI 10.1590/S1807-59322011000700031 | - |
hcfmusp.relation.reference | Cottin V, 2012, EUR RESPIR J, V40, P630, DOI 10.1183/09031936.00093111 | - |
hcfmusp.relation.reference | Damico R, 2015, AM J RESP CRIT CARE, V191, P208, DOI 10.1164/rccm.201409-1742OC | - |
hcfmusp.relation.reference | Dweik RA, 2001, AM J RESP CELL MOL, V24, P414, DOI 10.1165/ajrcmb.24.4.4127 | - |
hcfmusp.relation.reference | Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108 | - |
hcfmusp.relation.reference | Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x | - |
hcfmusp.relation.reference | Hrycek A, 2009, RHEUMATOL INT, V30, P175, DOI 10.1007/s00296-009-0930-7 | - |
hcfmusp.relation.reference | Iyer AS, 2014, CHEST, V145, P824, DOI 10.1378/chest.13-1422 | - |
hcfmusp.relation.reference | Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209 | - |
hcfmusp.relation.reference | Lima BLG, 2004, MAYO CLIN PROC, V79, P42, DOI 10.4065/79.1.42 | - |
hcfmusp.relation.reference | McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391 | - |
hcfmusp.relation.reference | Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729, DOI 10.1590/S0100-879X1999000600008 | - |
hcfmusp.relation.reference | RASHAD SM, 2012, ANN RHEUM DIS S3, V71, P269 | - |
hcfmusp.relation.reference | Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC | - |
hcfmusp.relation.reference | STEEN VD, 1992, ARTHRITIS RHEUM, V35, P765, DOI 10.1002/art.1780350709 | - |
hcfmusp.relation.reference | Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867 | - |
hcfmusp.relation.reference | Taveira-DaSilva AM, 2007, CHEST, V132, P1573, DOI 10.1378/chest.07-1205 | - |
hcfmusp.relation.reference | Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007 | - |
hcfmusp.relation.reference | Walkup LL, 2015, ANN AM THORAC SOC, pA5009 | - |
hcfmusp.relation.reference | Wells JM, 2013, INT J CHRONIC OBSTR, V8, P509, DOI 10.2147/COPD.S52204 | - |
hcfmusp.relation.reference | Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830 | - |
hcfmusp.relation.reference | Xu KF, 2013, RESP MED, V107, P263, DOI 10.1016/j.rmed.2012.10.006 | - |
hcfmusp.relation.reference | Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0 | - |
hcfmusp.relation.reference | Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573 | - |
hcfmusp.relation.reference | Zafar MA, 2013, AM J RESP CRIT CARE, V188, P1167, DOI 10.1164/rccm.201304-0618LE | - |
dc.description.index | PubMed | - |
hcfmusp.citation.scopus | 3 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCP Artigos e Materiais de Revistas Científicas - HC/InCor Artigos e Materiais de Revistas Científicas - LIM/09 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_COURTWRIGHT_CHARACTERIZATION_OF_LYMPHANGIOLEIOMYOMATOSIS_PATIENTS_WITH_DISCORDANCE_BETWEEN_SPIROMETRIC_2018.PDF Restricted Access | publishedVersion (English) | 530.6 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.